Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes

Published:2017-08-02 Issue:9 Volume:26 Page:1083-1089
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Tan Xueying¹,Cao Xiaojing²,Zhou Minzhi³,Zou Ping⁴,Hu Jingbo⁵

Affiliation:

1. College of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, China

2. Department of Pharmacy, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China

3. School of Medicine, Zhejiang University City College, Hangzhou, China

4. Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

5. College of Pharmaceutical Science, Zhejiang University, Hangzhou, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1360274

Reference43 articles.

1. CDC, Department of health and human services [homepage on the Internet]. National diabetes statistics report, 2014. updated 2014; cited 2015 May 15. Available from: http://www.cdc.gov//diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 2014 Sept 28

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review;Cureus;2024-08-17

2. New and emerging treatments for metabolic dysfunction-associated steatohepatitis;Cell Metabolism;2024-05

3. Clinical Trial Landscape in NASH;Clinical Gastroenterology and Hepatology;2023-07

4. Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes;Biomedicines;2023-05-04

5. Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2022-09-14